<VariationArchive VariationID="8550" VariationName="NM_001365276.2(TNXB):c.3290_3291del (p.Lys1097fs)" VariationType="Deletion" Accession="VCV000008550" Version="12" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2018-06-02" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23589" VariationID="8550">
      <GeneList>
        <Gene Symbol="TNXB" FullName="tenascin XB" GeneID="7148" HGNC_ID="HGNC:11976" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p21.33-21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167246.2" start="3369799" stop="3403209" display_start="3369799" display_stop="3403209" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167247.2" start="3383186" stop="3451358" display_start="3383186" display_stop="3451358" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167245.2" start="3282561" stop="3350704" display_start="3282561" display_stop="3350704" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167248.2" start="3264388" stop="3309331" display_start="3264388" display_stop="3309331" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167249.2" start="3342340" stop="3369633" display_start="3342340" display_stop="3369633" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32041153" stop="32109338" display_start="32041153" display_stop="32109338" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_113891.3" start="3479475" stop="3547671" display_start="3479475" display_stop="3547671" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167244.2" start="3406268" stop="3418727" display_start="3406268" display_stop="3418727" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="32008931" stop="32077150" display_start="32008931" display_stop="32077150" Strand="-" />
          </Location>
          <OMIM>600985</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001365276.2(TNXB):c.3290_3291del (p.Lys1097fs)</Name>
      <CanonicalSPDI>NC_000006.12:32084566:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32084567" stop="32084568" display_start="32084567" display_stop="32084568" variantLength="2" positionVCF="32084566" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="32052344" stop="32052345" display_start="32052344" display_stop="32052345" variantLength="2" positionVCF="32052343" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K1097fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.32052345_32052346del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.32052345_32052346del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.32084568_32084569del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.32084568_32084569del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008337.2" sequenceAccession="NG_008337" sequenceVersion="2" change="g.29807_29808del">
            <Expression>NG_008337.2:g.29807_29808del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365276.2" sequenceAccession="NM_001365276" sequenceVersion="2" change="c.3290_3291del" MANESelect="true">
            <Expression>NM_001365276.2:c.3290_3291del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352205.1" sequenceAccession="NP_001352205" sequenceVersion="1" change="p.Lys1097fs">
            <Expression>NP_001352205.1:p.Lys1097fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_019105.8" sequenceAccession="NM_019105" sequenceVersion="8" change="c.3290_3291del">
            <Expression>NM_019105.8:c.3290_3291del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061978.6" sequenceAccession="NP_061978" sequenceVersion="6" change="p.Lys1097fs">
            <Expression>NP_061978.6:p.Lys1097fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_019105.6" sequenceAccession="NM_019105" sequenceVersion="6" change="c.3290_3291delAA">
            <Expression>NM_019105.6:c.3290_3291delAA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_019105.8" sequenceAccession="NM_019105" sequenceVersion="8" change="c.3290_3291delAA">
            <Expression>NM_019105.8:c.3290_3291delAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212898" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600985.0002" DB="OMIM" />
        <XRef Type="rs" ID="764070148" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 11642233 Fig. 4C to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001365276.2(TNXB):c.3290_3291del (p.Lys1097fs) AND not provided" Accession="RCV001582471" Version="13">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001365276.2(TNXB):c.3290_3291del (p.Lys1097fs) AND Ehlers-Danlos syndrome due to tenascin-X deficiency" Accession="RCV002051615" Version="11">
        <ClassifiedConditionList TraitSetID="2355">
          <ClassifiedCondition DB="MedGen" ID="C1848029">Ehlers-Danlos syndrome due to tenascin-X deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001365276.2(TNXB):c.3290_3291del (p.Lys1097fs) AND Cardiovascular phenotype" Accession="RCV002321475" Version="9">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-30" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-06-02" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11642233</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12865992</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-04-21">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2355" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2075" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos-like syndrome due to tenascin-X deficiency</ElementValue>
                <XRef ID="Ehlers-Danlos-Like+Syndrome+due+to+Tenascin-X+Deficiency/2492" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome due to tenascin-X deficiency</ElementValue>
                <XRef ID="MONDO:0011670" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS due to TNX deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TNX deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, CLASSIC-LIKE</ElementValue>
                <XRef Type="MIM" ID="606408" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, classic-like, 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDSCLL1</ElementValue>
                <XRef Type="MIM" ID="606408" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8507" />
                <XRef ID="8507" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TNXB-Related Classic-Like Ehlers-Danlos Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The clinical features of TNXB-related classical-like Ehlers-Danlos syndrome (clEDS) strongly resemble those seen in classic EDS (cEDS). Affected individuals have generalized joint hypermobility, hyperextensible skin, and easy bruising, but do not have atrophic scarring, as is seen in cEDS. There are also several other distinguishing clinical findings including anomalies of feet and hands, edema in the legs in the absence of cardiac failure, mild proximal and distal muscle weakness, and axonal polyneuropathy. Vaginal, uterine, and/or rectal prolapse can also occur. Tissue fragility with resulting rupture of the trachea, esophagus, and small and large bowel has been reported. Vascular fragility causing a major event occurs in a minority of individuals. Significant variability in the severity of musculoskeletal symptoms and their effect on day-to-day function between unrelated affected individuals as well as among affected individuals in the same family has been reported. Fatigue has been reported in more than half of affected individuals. The severity of symptoms in middle-aged individuals can range from joint hypermobility without complications to being wheelchair-bound as a result of severe and painful foot deformities and fatigue.</Attribute>
                <XRef ID="NBK584019" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TNXB-Related Classical-Like Ehlers-Danlos Syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36108117</ID>
                <ID Source="BookShelf">NBK584019</ID>
              </Citation>
              <XRef ID="230839" DB="Orphanet" />
              <XRef ID="C1848029" DB="MedGen" />
              <XRef ID="MONDO:0011670" DB="MONDO" />
              <XRef Type="MIM" ID="606408" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29297" SubmissionDate="2018-05-30" DateLastUpdated="2018-06-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600985.0002_EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 1" title="TNXB, 2-BP DEL, 56063AA_EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 1" />
        <ClinVarAccession Accession="SCV000029297" DateUpdated="2018-06-02" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with Ehlers-Danlos syndrome (EDSCLL1; 606408), Schalkwijk et al. (2001) identified a homozygous 2-bp deletion, 56063_56064delAA, in exon 8 of the TNXB gene. The 2-bp deletion altered the open reading frame, affecting amino acids 1184 through 1230, after which a premature stop codon was encountered. The patient's clinically normal father was heterozygous for the deletion; the mother could not be studied. One sister carried the deletion. An unrelated patient was also homozygous for this mutation, but her parents were unavailable for study.</Attribute>
              <Citation>
                <ID Source="PubMed">11642233</ID>
              </Citation>
              <XRef DB="OMIM" ID="606408" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with a hypermobility type of Ehlers-Danlos syndrome, Zweers et al. (2003) identified heterozygosity for the 56063_56064delAA mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">12865992</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNXB" />
          </GeneList>
          <Name>TNXB, 2-BP DEL, 56063AA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 56063AA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600985.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7197006" SubmissionDate="2023-04-06" DateLastUpdated="2023-04-09" DateCreated="2023-04-09">
        <ClinVarSubmissionID localKey="SUB13034833" submittedAssembly="hg19" title="SUB13034833" />
        <ClinVarAccession Accession="SCV003853253" DateUpdated="2023-04-09" DateCreated="2023-04-09" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">11642233</ID>
          </Citation>
          <Comment>A Heterozygous Frameshift variant c.3290_3291delAA in Exon 8 of the TNXB gene that results in the amino acid substitution p.Lys1097fs*48 was identified. The observed variant has a minor allele frequency of 0.00002/0.00010 in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Likely Pathogenic [Variant ID: 8550]. This mutation has been detected as homozygous in two individuals from an Ehlers-Danlos syndrome (EDS) cohort (Schalkwijk J et al. 2001). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNXB">
              <Name>tenascin XB</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_019105.8:exon 8</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs764070148" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_019105.8:c.3290_3291delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606408" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13034833</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3558464" SubmissionDate="2022-04-20" DateLastUpdated="2023-03-04" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="GDXSV:224935" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001820244" DateUpdated="2023-03-04" DateCreated="2021-09-08" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>In a Letter to the Editor from the authors of Schalkwijk et al. (2001), the group reports additional workup on the family members of their previous cohort; authors observed that heterozygous family members were found to have significantly reduced tenascin X levels with a female-skewed preponderance for joint hypermobility (Zweers et al., 2003); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26582918, 11642233, 12865992)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNXB" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:742950</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_019105.6:c.3290_3291del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_101_20220420054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_28_20210831083931</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5096336" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a856961|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002606043" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11642233</ID>
          </Citation>
          <Comment>The c.3290_3291delAA pathogenic mutation, located in coding exon 7 of the TNXB gene, results from a deletion of two nucleotides at nucleotide positions 3290 to 3291, causing a translational frameshift with a predicted alternate stop codon (p.K1097Rfs*48). This mutation has been detected as homozygous in two individuals from an Ehlers-Danlos syndrome (EDS) cohort (Schalkwijk J et al. N. Engl. J. Med., 2001 Oct;345:1167-75). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TNXB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_019105.6:c.3290_3291delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5096336" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3558464" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7197006" TraitType="Disease" MappingType="XRef" MappingValue="606408" MappingRef="OMIM">
        <MedGen CUI="C1848029" Name="Ehlers-Danlos syndrome due to tenascin-X deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="29297" TraitType="Disease" MappingType="Name" MappingValue="EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 1" MappingRef="Preferred">
        <MedGen CUI="C1848029" Name="Ehlers-Danlos syndrome due to tenascin-X deficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2015-04-15">SCV000029298</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

